CHILDRENS IBUPROFEN ORAL SUSPENSION
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHILDRENS IBUPROFEN ORAL SUSPENSION, covering 2024-11-08 to 2024-11-08. Get the full timeline:
Most recent: FDA Approved: CHILDRENS IBUPROFEN ORAL SUSPENSION — Original Application (PAI Holdings, LLC dba PAI Pharma)